Victory Capital Management
INBX icon

Victory Capital Management’s Inhibrx INBX Stock Holding History

Victory Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$734K Sell
10,924
-1,039
-9% -$77.1K ﹤0.01% 1944
2025
Q4 		$945K Buy
+11,963
New +$815K ﹤0.01% 1863

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Victory Capital Management's INBX Position: Q1 2026 in Review

Victory Capital Management reduced its Inhibrx (INBX) stake by 8.7% in Q1 2026, selling an estimated $77.1K and leaving 10,924 shares worth $734K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

Victory Capital Management first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $945K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Victory Capital Management held 10,924 shares of Inhibrx worth $734K as of Q1 2026.
  • Victory Capital Management sold 1,039 Inhibrx shares in Q1 2026, an estimated $77.1K.
  • Inhibrx made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1944 holding.
  • Victory Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • Victory Capital Management's Inhibrx position peaked at $945K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.